Rogers T, Sok K, Erickson T, Aguilera E, Wootton SH, Murray KO, et al. The comparison of Gram-positive and Gram-negative healthcare-associated ventriculitis and meningitis in adults and children. Intensive Care Med. 2020;46(1):128–31.
Google Scholar
Srihawan C, Castelblanco RL, Salazar L, Wootton SH, Aguilera E, Ostrosky-Zeichner L, et al. Clinical characteristics and predictors of adverse outcome in adult and pediatric patients with healthcare-associated ventriculitis and meningitis. Open Forum Infect Dis. 2016;3(2): ofw077.
Google Scholar
Shi Z-H, Xu M, Wang Y-Z, Luo X-Y, Chen G-Q, Wang X, et al. Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients. Br J Neurosurg. 2017;31(1):5–9.
Google Scholar
Rogers T, Sok K, Erickson T, Aguilera E, Wootton SH, Murray KO, et al. Impact of antibiotic therapy in the microbiological yield of Healthcare-Associated ventriculitis and meningitis. Open Forum Infect Dis. 2019;6(3): ofz050.
Google Scholar
Shrestha S, Kharel S, Homagain S, Aryal R, Mishra SK. Prevalence of vancomycin-resistant enterococci in Asia-a systematic review and meta-analysis. J Clin Pharm Ther. 2021;46(5):1226–37.
Google Scholar
Tsai H-Y, Lee Y-L, Liu P-Y, Lu M-C, Shao P-L, Lu P-L, et al. Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: results from the 2019–2020 nationwide surveillance of multicenter antimicrobial resistance in Taiwan (SMART). Int J Antimicrob Agents. 2021;58(1): 106353.
Google Scholar
Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 infectious diseases society of america’s clinical practice guidelines for Healthcare-Associated ventriculitis and meningitis. Clin Infect Dis. 2017;64(6):e34–65.
Google Scholar
Wang JS, Muzevich K, Edmond MB, Bearman G, Stevens MP. Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature. Int J Infect Dis. 2014;25:26–31.
Google Scholar
Knoll BM, Hellmann M, Kotton CN. Vancomycin-resistant Enterococcus faecium meningitis in adults: case series and review of the literature. Scand J Infect Dis. 2013;45(2):131–9.
Google Scholar
Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother. 2010;44(12):2001–6.
Google Scholar
Lee BJ, Vu BN, Seddon AN, Hodgson HA, Wang SK. Treatment considerations for CNS infections caused by Vancomycin-Resistant Enterococcus faecium: a focused review of linezolid and daptomycin. Ann Pharmacother. 2020;54(12):1243–51.
Google Scholar
Khanum I, Anwar S, Farooque A. Enterococcal meningitis/ventriculitis: a tertiary care experience. Asian J Neurosurg. 2019;14(1):102–5.
Google Scholar
Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards Institute performance standards for antimicrobial susceptibility testing, M100, 31st edition. J Clin Microbiol. 2021;59(12):e0021321.
Google Scholar
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1(7905):480–4.
Google Scholar
Weiner-Lastinger LM, Abner S, Benin AL, Edwards JR, Kallen AJ, Karlsson M, et al. Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: summary of data reported to the national healthcare safety network, 2015–2017. Infect Control Hosp Epidemiol. 2020;41(1):19–30.
Google Scholar
Weiner-Lastinger LM, Abner S, Edwards JR, Kallen AJ, Karlsson M, Magill SS, et al. Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National healthcare safety network, 2015–2017. Infect Control Hosp Epidemiol. 2020;18. https://doi.org/10.1017/ice.2019.296.
Weiner LM, Webb AK, Limbago B, Dudeck MA, Patel J, Kallen AJ, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect Control Hosp Epidemiol. 2016;37(11):1288–301.
Google Scholar
Ding L, Yang Y, Zheng C, Sun G, Han R, Guo Y, et al. Activities of eravacycline, tedizolid, norvancomycin, nemonoxacin, ceftaroline, and comparators against 1,871 Staphylococcus and 1,068 Enterococcus species isolates from china: updated report of the CHINET study 2019. Microbiol Spectr. 2022;10(6):e0171522.
Google Scholar
Ayobami O, Willrich N, Reuss A, Eckmanns T, Markwart R. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microbes Infect. 2020;9(1):1180–93.
Google Scholar
Gök ŞM, Türk Dağı H, Kara F, Arslan U, Fındık D. [Investigation of antibiotic resistance and virulence factors of Enterococcus faecium and Enterococcus faecalis strains isolated from clinical samples]. Mikrobiyol Bul. 2020;54(1):26–39.
Google Scholar
Aznar J, Lepe JA, Dowzicky MJ, Surveillance Study. J Chemother. 2012;24(2):2004–9.
Google Scholar
Pintado V, Pazos R, Jiménez-Mejías ME, Rodríguez-Guardado A, Díaz-Pollán B, Cabellos C, et al. Linezolid for therapy of Staphylococcus aureus meningitis: a cohort study of 26 patients. Infectious Diseases. 2020;52(11):808–15.
Google Scholar
Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist. 1996;2(2):209–13.
Google Scholar
Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993;37(8):1563–71.
Google Scholar
Mlaga KD, Garcia V, Colson P, Ruimy R, Rolain J-M, Diene SM. Extensive comparative genomic analysis of Enterococcus faecalis and Enterococcus faecium reveals a direct association between the absence of CRISPR-Cas systems, the presence of anti-endonuclease (ardA) and the acquisition of vancomycin resistance in E. faecium. Microorganisms. 2021. https://doi.org/10.3390/microorganisms9061118.
Google Scholar
Herrera-Hidalgo L, López-Cortes LE, Luque-Márquez R, Gálvez-Acebal J, de Alarcón A, López-Cortes LF, et al. Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy. Antimicrob Agents Chemother. 2020. https://doi.org/10.1128/AAC.00309-20.
Google Scholar
Del Rosselli E, Bartoletti M, Dahl A, Cervera C, Pericàs JM. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2021;27(3):364–71.
Google Scholar
Karvouniaris M, Aidoni Z, Gkeka E, Primikyri SN, Pagioulas K, Argiriadou E. Treatment options for nosocomial ventriculitis/meningitis: a case report and review of the literature. Pathogens. 2024. https://doi.org/10.3390/pathogens14010003.
Google Scholar
Nau R, Seele J, Eiffert H. New antibiotics for the treatment of nosocomial central nervous system infections. Antibiotics. 2024. https://doi.org/10.3390/antibiotics13010058.
Google Scholar
Nau R, Kinzig-Schippers M, Sörgel F, Schinschke S, Rössing R, Müller C, et al. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients. Antimicrob Agents Chemother. 1997;41(5):987–91.
Google Scholar
Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, et al. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC Infect Dis. 2021;21(1):153.
Google Scholar
Blassmann U, Hope W, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, et al. CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study. J Antimicrob Chemother. 2019;74(4):991–6.
Google Scholar